Related Experiment Video
Updated: Aug 2, 2026

10:19
Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models
Published on: August 9, 2012
Tissue-bonding cystostomy: potential alternative for neuropathic bladder dysfunction and potential model for other
1Scott Department of Urology, Baylor College of Medicine, Houston, Texas, USA. dpgriff@swbell.net
Journal of Endourology
|March 29, 2000
Summary
Neuropathic bladder dysfunction causes urinary issues. A new tissue-bonding cystostomy device using infection-resistant materials aims to reduce catheter-associated bacteriuria in patients.
Area of Science:
- Urology
- Biomaterials Science
- Infectious Disease Prevention
Background:
- Neuropathic bladder dysfunction frequently leads to urinary retention and incontinence.
- Current management often involves catheterization, increasing the risk of bacteriuria.
- There is a need for improved bladder management solutions to prevent infections.
Purpose of the Study:
- To describe the development of a novel tissue-bonding cystostomy device.
- To evaluate the potential of this device in managing neuropathic bladder dysfunction.
- To assess the device's ability to mitigate infection risks associated with bladder management.
Main Methods:
- Construction of a prototype cystostomy device incorporating infection-resistant materials.
- Design focused on creating a closed ecosystem to minimize contamination.
- Early-stage trials were conducted to assess device performance and biocompatibility.
Main Results:
- A prototype tissue-bonding cystostomy device was successfully constructed.
- The device integrates infection-resistant materials and a closed-system design.
- Early trial results indicate the device's potential for managing neuropathic bladder dysfunction.
Conclusions:
- The developed tissue-bonding cystostomy device represents a promising innovation.
- This device may offer an alternative to traditional catheterization for neuropathic bladder patients.
- Further research and clinical trials are warranted to confirm efficacy and safety.

